[PHARMA] QoQ Cumulative Quarter Result on 30-Sep-2012 [#3]

Stock
[PHARMA] PHARMANIAGA BHD
Announcement Date
06-Nov-2012
Admission Sponsor
-
Sponsor
-
Financial Year
31-Dec-2012
Quarter
30-Sep-2012 [#3]
Profit Trend
QoQ- 56.87%
YoY- 73.18%
Quarter Report
Latest QR
Upcoming QR
PHARMA's Result
PHARMA's Financial Summary
View:
Show?
Cumulative Result
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Revenue 937,972 500,339 1,812,346 1,329,942 903,482 446,745 1,520,981 -27.57%
PBT 46,529 36,924 103,313 99,066 70,573 42,955 73,186 -26.08%
Tax -15,205 -11,771 -40,108 -28,392 -25,435 -13,894 -20,401 -17.81%
NP 31,324 25,153 63,205 70,674 45,138 29,061 52,785 -29.40%
-
NP to SH 30,636 24,771 61,710 69,645 44,398 28,685 52,157 -29.88%
-
Tax Rate 32.68% 31.88% 38.82% 28.66% 36.04% 32.35% 27.88% -
Total Cost 906,648 475,186 1,749,141 1,259,268 858,344 417,684 1,468,196 -27.50%
-
Net Worth 481,681 484,829 471,886 496,623 481,282 474,161 514,273 -4.27%
Dividend
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Div 17,661 8,825 41,187 29,420 17,650 8,824 35,304 -37.00%
Div Payout % 57.65% 35.63% 66.74% 42.24% 39.76% 30.76% 67.69% -
Equity
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Net Worth 481,681 484,829 471,886 496,623 481,282 474,161 514,273 -4.27%
NOSH 258,968 117,676 117,677 117,683 117,672 117,657 117,682 69.26%
Ratio Analysis
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
NP Margin 3.34% 5.03% 3.49% 5.31% 5.00% 6.51% 3.47% -
ROE 6.36% 5.11% 13.08% 14.02% 9.22% 6.05% 10.14% -
Per Share
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 362.20 425.18 1,540.10 1,130.10 767.79 379.70 1,292.44 -57.20%
EPS 11.83 21.05 52.44 59.18 37.73 24.38 44.32 -58.57%
DPS 6.82 7.50 35.00 25.00 15.00 7.50 30.00 -62.78%
NAPS 1.86 4.12 4.01 4.22 4.09 4.03 4.37 -43.44%
Adjusted Per Share Value based on latest NOSH - 117,646
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
RPS 65.08 34.72 125.75 92.28 62.69 31.00 105.53 -27.56%
EPS 2.13 1.72 4.28 4.83 3.08 1.99 3.62 -29.80%
DPS 1.23 0.61 2.86 2.04 1.22 0.61 2.45 -36.85%
NAPS 0.3342 0.3364 0.3274 0.3446 0.3339 0.329 0.3568 -4.27%
Price Multiplier on Financial Quarter End Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 28/06/13 29/03/13 31/12/12 28/09/12 29/06/12 30/03/12 30/12/11 -
Price 4.49 8.26 8.10 7.55 10.18 5.90 5.36 -
P/RPS 1.24 1.94 0.53 0.67 1.33 1.55 0.41 109.27%
P/EPS 37.95 39.24 15.45 12.76 26.98 24.20 12.09 114.53%
EY 2.63 2.55 6.47 7.84 3.71 4.13 8.27 -53.44%
DY 1.52 0.91 4.32 3.31 1.47 1.27 5.60 -58.11%
P/NAPS 2.41 2.00 2.02 1.79 2.49 1.46 1.23 56.64%
Price Multiplier on Announcement Date
30/06/13 31/03/13 31/12/12 30/09/12 30/06/12 31/03/12 31/12/11 CAGR
Date 16/08/13 15/05/13 18/02/13 06/11/12 08/08/12 03/05/12 22/02/12 -
Price 4.66 9.26 7.80 8.25 8.83 5.90 5.90 -
P/RPS 1.29 2.18 0.51 0.73 1.15 1.55 0.46 98.98%
P/EPS 39.39 43.99 14.87 13.94 23.40 24.20 13.31 106.26%
EY 2.54 2.27 6.72 7.17 4.27 4.13 7.51 -51.48%
DY 1.46 0.81 4.49 3.03 1.70 1.27 5.08 -56.48%
P/NAPS 2.51 2.25 1.95 1.95 2.16 1.46 1.35 51.26%

PBT = Profit before Tax, NP = Net Profit, NP to SH = Net Profit Attributable to Shareholder, Div = Dividend, NP Margin = Net Profit Margin, ROE = Return on Equity, NOSH = Number of Shares, RPS = Revenue per Share, EPS = Earning Per Share, DPS = Dividend Per Share, NAPS = Net Asset Per Share, EOQ = End of Quarter, ANN = Announcement, P/RPS = Price/Revenue per Share, P/EPS = Price/Earning per Share, P/NAPS = Price/Net Asset per Share, EY = Earning Yield, DY = Dividend Yield.

NOSH is estimated based on the NP to SH and EPS. Div is an estimated figure based on the DPS and NOSH. Net Worth is an estimated figure based on the NAPS and NOSH.

Div Payout %, NP Margin, ROE, DY, QoQ ⃤ & YoY ⃤ figures in Percentage; RPS, EPS & DPS's figures in Cent; and NAPS's figures in Dollar.

All figures in '000 unless specified.

Discussions
Be the first to like this. Showing 0 of 0 comments
Post a Comment